Undervalued Large-Cap Healthcare Stocks on NYS September 2024

September 20, 2024

Healthcare Sector

The healthcare sector includes companies in biotechnology, pharmaceuticals, hospitals, home and long-term care. It also includes related medical equipment manufacturers and suppliers.

New York Stock Exchange

The New York Stock Exchange, located in New York City, is the largest securities exchange in the world by market capitalization of its listed companies.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Healthcare stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
PRGO Perrigo 28.16 51.68 83.51 977083 3861 3.96 0.0
BAX Baxter Intl 39.37 63.27 60.72 3335641 20079 2.99 0.0
ELAN Elanco Animal Health 14.65 19.05 30.03 3523283 7240 0.00 0.0
BIO.B Bio-Rad Laboratories 326.74 407.85 24.82 6 9278 0.00 0.0
NVST Envista Holdings 19.18 23.58 22.94 2446110 3301 0.00 0.0
BIO Bio-Rad Laboratories 340.45 414.36 21.71 216404 9667 0.00 0.0
ZBH Zimmer Biomet Holdings 106.28 128.63 21.03 1503009 21936 0.90 22.2
CNMD Conmed 76.01 91.74 20.69 363422 2364 1.06 24.0
CRL Charles River 206.10 246.11 19.41 575662 10685 0.00 25.1
BDX Becton Dickinson 231.59 275.59 19.00 1231295 67220 1.62 47.0
All data provided as at market close September 18, 2024.

Company Details

Perrigo

PRGO:NYS

Close Price

28.16

Our Valuation

51.68

% Difference

83.51

Market Cap ($M)

3861

P/E Ratio

0.0

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS.

Access the stockcalc valuation


Baxter Intl

BAX:NYS

Close Price

39.37

Our Valuation

63.27

% Difference

60.72

Market Cap ($M)

20079

P/E Ratio

0.0

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app.

Access the stockcalc valuation


Elanco Animal Health

ELAN:NYS

Close Price

14.65

Our Valuation

19.05

% Difference

30.03

Market Cap ($M)

7240

P/E Ratio

0.0

Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company's operations are conducted globally and sell its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production. The company's product portfolio of approximately 200 brands.

Access the stockcalc valuation


Bio-Rad Laboratories

BIO.B:NYS

Close Price

326.74

Our Valuation

407.85

% Difference

24.82

Market Cap ($M)

9278

P/E Ratio

0.0

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Envista Holdings

NVST:NYS

Close Price

19.18

Our Valuation

23.58

% Difference

22.94

Market Cap ($M)

3301

P/E Ratio

0.0

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables.

Access the stockcalc valuation


Bio-Rad Laboratories

BIO:NYS

Close Price

340.45

Our Valuation

414.36

% Difference

21.71

Market Cap ($M)

9667

P/E Ratio

0.0

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories.

Access the stockcalc valuation


Zimmer Biomet Holdings

ZBH:NYS

Close Price

106.28

Our Valuation

128.63

% Difference

21.03

Market Cap ($M)

21936

P/E Ratio

22.2

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products.

Access the stockcalc valuation


Conmed

CNMD:NYS

Close Price

76.01

Our Valuation

91.74

% Difference

20.69

Market Cap ($M)

2364

P/E Ratio

24.0

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

Access the stockcalc valuation


Charles River

CRL:NYS

Close Price

206.10

Our Valuation

246.11

% Difference

19.41

Market Cap ($M)

10685

P/E Ratio

25.1

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world.

Access the stockcalc valuation


Becton Dickinson

BDX:NYS

Close Price

231.59

Our Valuation

275.59

% Difference

19.00

Market Cap ($M)

67220

P/E Ratio

47.0

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Perrigo and Baxter Intl are the most undervalued Large-Cap Healthcare stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-september-2024
Perrigo $PRGO and Baxter Intl $BAX are the most undervalued Healthcare stocks on the #NYS. See the full list: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-september-2024
Perrigo and Baxter Intl are the most undervalued Large-Cap Healthcare stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-september-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.